For many dogs living with epilepsy, standard anti-seizure medications provide meaningful relief. But for some, seizures continue despite treatment. These cases are known as drug-resistant, or refractory, epilepsy — and they represent one of the most challenging problems in veterinary neurology. Fortunately, emerging research into cannabidiol (CBD) is offering new hope for these difficult cases.
What Is Drug-Resistant Epilepsy?
Idiopathic epilepsy is one of the most common neurological conditions in dogs. While medications like phenobarbital, levetiracetam, and potassium bromide help many patients, some dogs simply do not respond well enough to traditional therapy. When seizures remain frequent and uncontrolled despite appropriate medication, a dog is considered to have refractory epilepsy.
This is where CBD research becomes especially exciting.
What the 2023 Study Found
A landmark 2023 double-blind, crossover clinical trial published in the Journal of Veterinary Internal Medicine examined CBD specifically in dogs with drug-resistant idiopathic epilepsy. The study, conducted by Rozental et al., enrolled 51 dogs and evaluated CBD as an adjunct treatment — meaning it was used alongside existing anti-seizure medications, not as a replacement.
The results were encouraging. Dogs receiving CBD showed a meaningful reduction in seizure frequency compared to those receiving a placebo. Importantly, this was in a population of dogs that had already proven difficult to treat with conventional medications alone.
This study builds on earlier work by McGrath et al. (2019), which found that a broad-spectrum CBD product reduced seizure frequency by approximately 25–30% compared to placebo. Studies have further supported these findings using a CBD/CBDA-rich hemp extract in dogs with refractory seizures.
Together, these studies suggest that CBD may offer a real benefit where other treatments have fallen short.
Why CBD?
CBD interacts with the body’s endocannabinoid system, which plays a role in regulating neurological activity. Unlike THC — the psychoactive compound found in marijuana — CBD does not produce a “high” and is generally well-tolerated in dogs. Safety studies have shown that CBD supplementation is largely safe for long-term use in dogs at appropriate doses.
Important Considerations
While the research is promising, there are several key points veterinary professionals should keep in mind:
- Product quality matters. Not all CBD products are created equal. Look for products from companies that provide third-party testing for cannabinoid content, heavy metals, pesticides, and microbial contaminants.
- THC levels should stay below 0.3%. Products exceeding this threshold are classified as marijuana and can be toxic to dogs, who are far more sensitive to THC than humans.
Drug-resistant epilepsy is heartbreaking for both pets and their families. The growing body of research around CBD — especially the 2023 Rozental et al. double-blind crossover study — suggests that this supplement offers a meaningful addition to the treatment toolkit for refractory cases.
References
- Rozental AJ et al. The efficacy and safety of cannabidiol as adjunct treatment for drug-resistant idiopathic epilepsy in 51 dogs: A double-blinded crossover study. J Vet Intern Med. 2023;37(6):2291–2300.
- McGrath S et al. Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy. J Am Vet Med Assoc. 2019;254(11):1301–1308.
